Seattle life science companies raised only $395.9 million through the third quarter, on pace for the weakest year since at least 2022, as Savills' Q3 2026 data show vacancy rising 150 basis points to 18.9 percent while Bay Area funding and vacancy hold steadier.
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.

Signup for news and special announcements!
You have successfully joined our subscriber list.
The largest apartment project slated to finish in the Portland metro this...
ByThe RegistryOctober 20, 2026The three-story community at 6712 NE 88th St. extends a multi-market Alliance...
ByThe RegistryOctober 20, 2026The Port of Seattle closed its 2026 Alaska cruise season with a...
ByThe RegistryOctober 20, 2026CBRE's third-quarter 2026 Seattle office report places Crusoe Energy Systems' 46,000-square-foot expansion...
ByThe RegistryOctober 20, 2026